Asia Pacific Human Insulin Market 2020-2026 by Product Type (Drugs, Delivery Devices), Application (Type 1 Diabetes, Type 2 Diabetes, Others), Distribution Channel, and Country: Trend Forecast and Growth Opportunity

Publisher Name :
Date: 18-Jan-2020
No. of pages: 113

Asia Pacific human insulin market will grow by 9.74% annually over forecast years with a total addressable market cap of $66.02 billion for 2020-2026.

Highlighted with 37 tables and 56 figures, this 113-page report "Asia Pacific Human Insulin Market 2020-2026 by Product Type (Drugs, Delivery Devices), Application (Type 1 Diabetes, Type 2 Diabetes, Others), Distribution Channel, and Country: Trend Forecast and Growth Opportunity" is based on a comprehensive research of the entire Asia Pacific human insulin market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. In this report 2019 is the base year for market analysis, with estimates and forecast covering 2020-2026. (Please Note: The report will be updated before delivery to make sure that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

- Market Structure

- Growth Drivers

- Restraints and Challenges

- Emerging Product Trends & Market Opportunities

- Porter's Fiver Forces

The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view. The balanced (most likely) projection is used to quantify Asia Pacific human insulin market in every aspect of the classification from perspectives of Product Type, Application, Distribution Channel, and Country.

Based on product type, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.

- Human Insulin Drugs

- Human Insulin Delivery Devices

Based on product, the Asia Pacific Human Insulin Drugs market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.

- Modern Human Insulin (further segmented into Long-acting, Rapid- acting, Premixed by type; further segmented into Lantus, Apidra, Levemir, NovoRapid/ NovoLog, Novomix, Humalog, Others by brand)

- Traditional Human Insulin (further segmented into Short-acting, Intermediate & Rapid-acting, Premixed by type; further segmented into Humulin, Insuman, Novolin/Actrapid/Insulatard by brand)

Based on product, the Asia Pacific Human Insulin Delivery Devices market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.

- Syringes

- Pens (further segmented into Disposable, Reusable, Pen needles)

- Pumps

- Others

Based on application, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.

- Type 1 Diabetes

- Type 2 Diabetes

- Gestational Diabetes and Prediabetes

Based on distribution channel, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.

- Hospital Pharmacies

- Retail Pharmacies

- Online Pharmacies

Geographically, the following national/local markets are fully investigated:

- Japan

- China

- South Korea

- Australia

- India

- Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)

For each of the aforementioned countries, market analysis and revenue data are available for 2019-2026. The breakdown of major national markets by Product Type, Application, and Distribution Channel over the study years (2019-2026) is included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in Asia Pacific human insulin market are assayed quantitatively and qualitatively through GMD's Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players:

Astra Zeneca PLC

Biocon

Eli Lilly

Exir

Julphar

Novo Nordisk AS

Pfizer

Sanofi Aventis

Sedico

Wockhardt

(Please Note: The report will be updated before delivery to make sure that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Asia Pacific Human Insulin Market 2020-2026 by Product Type (Drugs, Delivery Devices), Application (Type 1 Diabetes, Type 2 Diabetes, Others), Distribution Channel, and Country: Trend Forecast and Growth Opportunity

Table of Contents
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 10
1.2.1 Overview of Market Research Methodology 10
1.2.2 Market Assumption 11
1.2.3 Secondary Data 11
1.2.4 Primary Data 11
1.2.5 Data Filtration and Model Design 12
1.2.6 Market Size/Share Estimation 13
1.2.7 Research Limitations 14
1.3 Executive Summary 15
2 Market Overview and Dynamics 17
2.1 Market Size and Forecast 17
2.2 Major Growth Drivers 18
2.3 Market Restraints and Challenges 21
2.4 Emerging Opportunities and Market Trends 24
2.5 Porter's Fiver Forces Analysis 27
3 Segmentation of Asia-Pacific Market by Product Type 31
3.1 Market Overview by Product Type 31
3.2 Human Insulin Drugs 33
3.3 Human Insulin Delivery Devices 34
4 Segmentation of Asia-Pacific Human Insulin Drugs Market by Drug Product 35
4.1 Market Overview by Drug Product 35
4.2 Modern Human Insulin 37
4.2.1 Modern Human Insulin by Type 39
4.2.2 Modern Human Insulin by Brand 42
4.3 Traditional Human Insulin 49
4.3.1 Traditional Human Insulin by Type 51
4.3.2 Traditional Human Insulin by Brand 54
5 Segmentation of Asia-Pacific Human Insulin Delivery Devices Market by Device Product 57
5.1 Market Overview by Product 57
5.2 Syringes 59
5.3 Pens 60
5.4 Pumps 61
5.5 Other Devices 63
6 Segmentation of Asia-Pacific Market by Application 64
6.1 Market Overview by Application 64
6.2 Type 1 Diabetes 66
6.3 Type 2 Diabetes 67
6.4 Gestational Diabetes and Prediabetes 68
7 Segmentation of Asia-Pacific Market by Distribution Channel 69
7.1 Market Overview by Distribution Channel 69
7.2 Hospital Pharmacies 71
7.3 Retail Pharmacies 72
7.4 Online Pharmacies 73
8 Asia-Pacific Market 2019-2026 by Country 74
8.1 Overview of Asia-Pacific Market 74
8.2 Japan 77
8.3 China 80
8.4 Australia 82
8.5 India 84
8.6 South Korea 86
8.7 Rest of APAC Region 88
9 Competitive Landscape 90
9.1 Overview of Key Vendors 90
9.2 New Product Launch, Partnership, Investment, and M&A 94
9.3 Company Profiles 96
Astra Zeneca PLC 96
Biocon 98
Eli Lilly 99
Exir 100
Julphar 101
Novo Nordisk AS 102
Pfizer 103
Sanofi Aventis 104
Sedico 105
Wockhardt 106
10 Investing in Asia-Pacific Market: Risk Assessment and Management 107
10.1 Risk Evaluation of Asia-Pacific Market 107
10.2 Critical Success Factors (CSFs) 110
Related Reports and Products 113

List of Tables

Table 1. Snapshot of Asia-Pacific Human Insulin Market, 2019-2026 16
Table 2. Main Product Trends and Market Opportunities in Asia-Pacific Human Insulin Market 24
Table 3. Asia-Pacific Human Insulin Market by Product Type, 2019-2026, $ mn 31
Table 4. Asia-Pacific Human Insulin Drugs Market by Product, 2019-2026, $ mn 35
Table 5. Asia-Pacific Human Insulin Drugs Market: Modern Human Insulin by Type, 2019-2026, $ mn 38
Table 6. Asia-Pacific Human Insulin Drugs Market: Modern Human Insulin by Brand, 2019-2026, $ mn 38
Table 7. Asia-Pacific Human Insulin Drugs Market: Traditional Human Insulin by Type, 2019-2026, $ mn 50
Table 8. Asia-Pacific Human Insulin Drugs Market: Traditional Human Insulin by Brand, 2019-2026, $ mn 50
Table 9. Asia-Pacific Human Insulin Delivery Devices Market by Product, 2019-2026, $ mn 57
Table 10. Asia-Pacific Human Insulin Delivery Devices Market: Pens by Product, 2019-2026, $ mn 60
Table 11. Asia-Pacific Human Insulin Market by Application, 2019-2026, $ mn 64
Table 12. Asia-Pacific Human Insulin Market by Distribution Channel, 2019-2026, $ mn 69
Table 13. APAC Human Insulin Market by Country, 2019-2026, $ mn 75
Table 14. Japan Human Insulin Market by Product Type, 2019-2026, $ mn 79
Table 15. Japan Human Insulin Market by Application, 2019-2026, $ mn 79
Table 16. Japan Human Insulin Market by Distribution Channel, 2019-2026, $ mn 79
Table 17. China Human Insulin Market by Product Type, 2019-2026, $ mn 81
Table 18. China Human Insulin Market by Application, 2019-2026, $ mn 81
Table 19. China Human Insulin Market by Distribution Channel, 2019-2026, $ mn 81
Table 20. Australia Human Insulin Market by Product Type, 2019-2026, $ mn 83
Table 21. Australia Human Insulin Market by Application, 2019-2026, $ mn 83
Table 22. Australia Human Insulin Market by Distribution Channel, 2019-2026, $ mn 83
Table 23. India Human Insulin Market by Product Type, 2019-2026, $ mn 85
Table 24. India Human Insulin Market by Application, 2019-2026, $ mn 85
Table 25. India Human Insulin Market by Distribution Channel, 2019-2026, $ mn 85
Table 26. South Korea Human Insulin Market by Product Type, 2019-2026, $ mn 87
Table 27. South Korea Human Insulin Market by Application, 2019-2026, $ mn 87
Table 28. South Korea Human Insulin Market by Distribution Channel, 2019-2026, $ mn 87
Table 29. Human Insulin Market in Rest of APAC by Country, 2019-2026, $ mn 89
Table 30. Asia-Pacific Human Insulin Market by Key Vendor, 2019, $ mn 92
Table 31. Astra Zeneca PLC: Company Snapshot 96
Table 32. Astra Zeneca PLC: Business Segmentation 96
Table 33. Astra Zeneca PLC: Product Portfolio 97
Table 34. Astra Zeneca PLC: Revenue, 2016-2018, $ mn 97
Table 35. Astra Zeneca PLC: Recent Developments 97
Table 36. Risk Evaluation for Investing in Asia-Pacific Market, 2019-2026 108
Table 37. Critical Success Factors and Key Takeaways 111

List of Figures

Figure 1. Research Method Flow Chart 10
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 13
Figure 3. Asia-Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2026 15
Figure 4. Asia-Pacific Human Insulin Market, 2019-2026, $ mn 17
Figure 5. Primary Drivers and Impact Factors of Asia-Pacific Human Insulin Market 18
Figure 6. Primary Restraints and Impact Factors of Asia-Pacific Human Insulin Market 21
Figure 7. Porter's Fiver Forces Analysis of Asia-Pacific Human Insulin Market 27
Figure 8. Breakdown of Asia-Pacific Human Insulin Market by Product Type, 2019-2026, % of Revenue 31
Figure 9. Contribution to Asia-Pacific 2020-2026 Cumulative Revenue by Product Type, Value ($ mn) and Share (%) 32
Figure 10. Asia-Pacific Human Insulin Market: Human Insulin Drugs, 2019-2026, $ mn 33
Figure 11. Asia-Pacific Human Insulin Market: Human Insulin Delivery Devices, 2019-2026, $ mn 34
Figure 12. Breakdown of Asia-Pacific Human Insulin Drugs Market by Product, 2019-2026, % of Revenue 35
Figure 13. Contribution to Asia-Pacific Human Insulin Drugs Cumulative Revenue by Product, 2020-2026, Value ($ mn) and Share (%) 36
Figure 14. Asia-Pacific Human Insulin Market: Modern Human Insulin, 2019-2026, $ mn 37
Figure 15. Asia-Pacific Modern Human Insulin Market: Long-acting, 2019-2026, $ mn 39
Figure 16. Asia-Pacific Modern Human Insulin Market: Rapid- acting, 2019-2026, $ mn 40
Figure 17. Asia-Pacific Modern Human Insulin Market: Premixed, 2019-2026, $ mn 41
Figure 18. Asia-Pacific Modern Human Insulin Market: Lantus, 2019-2026, $ mn 42
Figure 19. Asia-Pacific Modern Human Insulin Market: Apidra, 2019-2026, $ mn 43
Figure 20. Asia-Pacific Modern Human Insulin Market: Levemir, 2019-2026, $ mn 44
Figure 21. Asia-Pacific Modern Human Insulin Market: NovoRapid/ NovoLog, 2019-2026, $ mn 45
Figure 22. Asia-Pacific Modern Human Insulin Market: Novomix, 2019-2026, $ mn 46
Figure 23. Asia-Pacific Modern Human Insulin Market: Humalog, 2019-2026, $ mn 47
Figure 24. Asia-Pacific Modern Human Insulin Market: Other Brands, 2019-2026, $ mn 48
Figure 25. Asia-Pacific Human Insulin Market: Traditional Human Insulin, 2019-2026, $ mn 49
Figure 26. Asia-Pacific Traditional Human Insulin Market: Short-acting, 2019-2026, $ mn 51
Figure 27. Asia-Pacific Traditional Human Insulin Market: Intermediate & Rapid-acting, 2019-2026, $ mn 52
Figure 28. Asia-Pacific Traditional Human Insulin Market: Premixed, 2019-2026, $ mn 53
Figure 29. Asia-Pacific Traditional Human Insulin Market: Humulin, 2019-2026, $ mn 54
Figure 30. Asia-Pacific Traditional Human Insulin Market: Insuman, 2019-2026, $ mn 55
Figure 31. Asia-Pacific Traditional Human Insulin Market: Novolin/Actrapid/Insulatard, 2019-2026, $ mn 56
Figure 32. Breakdown of Asia-Pacific Human Insulin Delivery Devices Market by Product, 2019-2026, % of Revenue 57
Figure 33. Contribution to Asia-Pacific Human Insulin Delivery Devices Cumulative Revenue by Product, 2020-2026, Value ($ mn) and Share (%) 58
Figure 34. Asia-Pacific Human Insulin Delivery Devices Market: Syringes, 2019-2026, $ mn 59
Figure 35. Asia-Pacific Human Insulin Delivery Devices Market: Pens, 2019-2026, $ mn 60
Figure 36. Asia-Pacific Human Insulin Delivery Devices Market: Pumps, 2019-2026, $ mn 61
Figure 37. Asia-Pacific Human Insulin Delivery Devices Market: Other Devices, 2019-2026, $ mn 63
Figure 38. Breakdown of Asia-Pacific Human Insulin Market by Application, 2019-2026, % of Revenue 64
Figure 39. Contribution to Asia-Pacific 2020-2026 Cumulative Revenue by Application, Value ($ mn) and Share (%) 65
Figure 40. Asia-Pacific Human Insulin Market: Type 1 Diabetes, 2019-2026, $ mn 66
Figure 41. Asia-Pacific Human Insulin Market: Type 2 Diabetes, 2019-2026, $ mn 67
Figure 42. Asia-Pacific Human Insulin Market: Gestational Diabetes and Prediabetes, 2019-2026, $ mn 68
Figure 43. Breakdown of Asia-Pacific Human Insulin Market by Distribution Channel, 2019-2026, % of Revenue 69
Figure 44. Contribution to Asia-Pacific 2020-2026 Cumulative Revenue by Distribution Channel, Value ($ mn) and Share (%) 70
Figure 45. Asia-Pacific Human Insulin Market: Hospital Pharmacies, 2019-2026, $ mn 71
Figure 46. Asia-Pacific Human Insulin Market: Retail Pharmacies, 2019-2026, $ mn 72
Figure 47. Asia-Pacific Human Insulin Market: Online Pharmacies, 2019-2026, $ mn 73
Figure 48. Breakdown of APAC Human Insulin Market by Country, 2019 and 2026, % of Revenue 75
Figure 49. Contribution to APAC 2020-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%) 76
Figure 50. Human Insulin Market in Japan, 2019-2026, $ mn 78
Figure 51. Human Insulin Market in China, 2019-2026, $ mn 80
Figure 52. Human Insulin Market in Australia, 2019-2026, $ mn 82
Figure 53. Human Insulin Market in India, 2019-2026, $ mn 84
Figure 54. Human Insulin Market in South Korea, 2019-2026, $ mn 86
Figure 55. Human Insulin Market in Rest of APAC, 2019-2026, $ mn 88
Figure 56. Growth Stage of Asia-Pacific Human Insulin Industry over the Forecast Period 90
  • Global and China Insulin Detemir Market Insights, Forecast to 2026
    Published: 29-Oct-2020        Price: US 3900 Onwards        Pages: 130
    Insulin Detemir market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Insulin Detemir market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Insulin Detemir market is segmented into......
  • Global and United States Diabetes Drug Market Size, Status and Forecast 2020-2026
    Published: 26-Oct-2020        Price: US 3900 Onwards        Pages: 132
    Global Diabetes Drug Scope and Market Size Diabetes Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Diabetes Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. Market segment by Type, the product can be split into - Insu......
  • (COVID-19 Version) Global Multiple Sclerosis (MS) Drugs Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
    Published: 24-Oct-2020        Price: US 3000 Onwards        Pages: 139
    Summary The report forecast global Multiple Sclerosis (MS) Drugs market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Multiple Sclerosis (MS) Drugs industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Multiple......
  • (COVID-19 Version) Global Musculoskeletal Disorders Drugs Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
    Published: 24-Oct-2020        Price: US 3000 Onwards        Pages: 97
    Summary The report forecast global Musculoskeletal Disorders Drugs market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Musculoskeletal Disorders Drugs industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Musc......
  • (COVID-19 Version) Global Metformin Hydrochloride Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
    Published: 22-Oct-2020        Price: US 3000 Onwards        Pages: 90
    Summary The report forecast global Metformin Hydrochloride market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Metformin Hydrochloride industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Metformin Hydrochlor......
  • Global Antidiabetic Biguanides Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
    Published: 22-Oct-2020        Price: US 3400 Onwards        Pages: 119
    The Antidiabetic Biguanides market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Antidiabetic Biguanides market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Antidiabetic Biguanides market. The report focuses on well-known providers in the global Antidiabetic Biguanides industry, market segments, ......
  • Global Diabetic Therapeutic Drugs Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
    Published: 22-Oct-2020        Price: US 3400 Onwards        Pages: 124
    The Diabetic Therapeutic Drugs market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Diabetic Therapeutic Drugs market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Diabetic Therapeutic Drugs market. The report focuses on well-known providers in the global Diabetic Therapeutic Drugs industry, marke......
  • Global Antidiabetic Thiazolidinediones Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
    Published: 20-Oct-2020        Price: US 3400 Onwards        Pages: 129
    The Antidiabetic Thiazolidinediones market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Antidiabetic Thiazolidinediones market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Antidiabetic Thiazolidinediones market. The report focuses on well-known providers in the global Antidiabetic Thiazolidinedi......
  • Global Liraglutide Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
    Published: 13-Oct-2020        Price: US 3400 Onwards        Pages: 119
    The Liraglutide market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Liraglutide market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Liraglutide market. The report focuses on well-known providers in the global Liraglutide industry, market segments, competition, and the macro environment. ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs